Review
Isoprostanes: Novel Bioactive Products of Lipid Peroxidation

References

• Nugteren, D.H., Vonkeman, H. and Van Dorf, D.A. (1967) "Non-enzymatic conversion of all-cis 8,11,14-eicosatrienoic acid into prostaglandin PGE1", Red. Tray. Chim.Pays-Bas. 86, 1237–1245.
   Google Scholar
• Porter, N.A. and Funk, M.O. (1975) "Peroxy radical cyclization as a model for prostaglandin synthesis", J. Org. Chem. 40, 3614–3615.
   PubMed Web of Science ®Google Scholar
• Mihelich, E.D. (1980) "Structure and stereochemistry of novel endoperoxide isolated from the sensitized photo-oxidation of methyl linoleate. Implication for prostaglandin biosynthesis", J. Am. Chem. Soc. 102, 7141–7143.
   Web of Science ®Google Scholar
• Morrow, J.D., Hill, K.E., Burk, R.F., Nammour, T.M., Badr, K.F. and Roberts, L.J., II (1990) "A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalysed mechanism", Proc. Natl Acad. Sci. USA 87, 9383–9387.
   PubMed Web of Science ®Google Scholar
• Morrow, J.D., Harris, T.M. and Roberts, L.J. II (1990) "Non-cyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramification for measure-ment of eicosanoids", Anal. Biochem. 184, 1–10.
   PubMed Web of Science ®Google Scholar
• Morrow, J.D., Awad, J.A., Boss, H.J., Blair, IA. and Roberts, L.J., II (1992) "Non-cyclooxygenase derived prostanoids (F2-isoprostanes) are formed in situ on phosphlipids", Proc. Natl Acad. Sci. USA 89, 10721–10725.
   PubMed Web of Science ®Google Scholar
• Roberts, L.J., II and Morrow, J.D. (2000) "Measurement of F2-isoprostanes as an index of oxidative stress in vivo", Free Radic. Biol. Med. 28, 505–513.
   PubMed Web of Science ®Google Scholar
• O'Connor, D.E., Mihelich, ED. and Coleman, M.C. (1984) "Stereochemical course of the autooxidised cydization of the lipid hydropermddes to prostaglandin-like bicyclo endoperoxides", J. Am. Chem. Soc. 106, 3577–3584.
   Web of Science ®Google Scholar
• Morrow, J.D. (2000) "The isoprostanes: their quantification as an index of oxidant stress status in vivo", Drug Metab. Rev. 32, 377–385.
   PubMed Web of Science ®Google Scholar
• Morrow, J.D., Minton, TA., Back, K.F. and Roberts, L.J., II (1994) "Evidence that F2- isoprostane, 8-epi-prostaglandin is formed in vivo", Biochim. Biophys. Acta 1210, 244–248.
   PubMed Web of Science ®Google Scholar
• Roberts, L.J., II and Morrow, J.D. (2002) "Products of isoprostane pathway: Unique bioactive compounds and markers of lipid peroxidation", Cell. Mol. Life Sci. 59, 808–820.
   PubMed Web of Science ®Google Scholar
• Brame, C.J., Salomon, R.G., Morrow, J.D. and Roberts, L.J., II (1999) "Identification of extreamly reactive y-ketoaldehydes (isolevuglandins) as products of isoprostane pathway and characterization of their lysyl protein adducts", J. Biol. Chem. 274, 13139–13146.
   PubMedGoogle Scholar
• Nourooz-Zadeh, J., Halliwell, B. and Anggird, E.E. (1997) "Evidence for the formation of F3-isoprostanes during peroxidation of eicosapentaenoic acid", Biochem. Biophys. Res. Commun. 236, 467–472.
   PubMed Web of Science ®Google Scholar
• Nourooz-Zadeh, J., Liu, E.H., Anggird, E. and Halliwell, B. (1998) "F4-isoprostanes during peroxidation of eicosapenta-enoic acid. A novel class of prostanoids formed during peroxidation of docosahexaenoic acid (DHA)", Biochem. Biophys. Res. Commun. 242, 338–344.
   PubMed Web of Science ®Google Scholar
• Morrow, J.D., Minton, T.A., Mukundan, C.R., Campbell, M.D., Zackert, W.E., Daniel, V.C., Back K.F., Blair, IA. and Roberts, L.J., II (1994) "Free radical-induced generation of isoprostanes in vivo", J. Biol. Chem. 269, 4317–4326.
   Google Scholar
• Basu, S. (1998) "Radioimmunoassay of 8-iso-prostaglandin F2,Z. an index for oxidative injury via free radical catalysed lipid peroxidation", Prostaglandins Leukot. Essent. Fatty Acids 58, 319–325.
   PubMed Web of Science ®Google Scholar
• Basu, S. (1998) "Radioimmunoassay of 15-keto-13,14-dihydro-prostaglandin F2e,.. an index for inflammation via cyclooxygenase catalysed lipid peroxidation", Prostaglan-dins Leukot. Essent. Fatty Acids 58, 347–352.
   PubMed Web of Science ®Google Scholar
• Roberts, L.J., II, Moore, K.P., Zackert, W.E., Oates, J.A. and Morrow, J.D. (1996) "Identification of the major urinary metabolite of the F2-isoprostane, 8-epi-prostaglandin Fly in humans", J. Biol. Chem. 271, 20617–20620.
   Google Scholar
• Chiabrando, C., Valagussa, A., Rivalta, C., Durand, T., Guy, A., Zuccato, E., Villa, P., Rossi, J.C. and Fanelli, R. (1999) "Identification and of measurement of endogenous beta oxidation metabolites of 8-epi-prostaglandin F2e,", J. Biol. Chem. 274, 1313–1319.
   PubMedGoogle Scholar
• Basu, S. (1998) "Metabolism of 8-iso-prostaglandin F2e,", FEBS Lett. 428, 32–36.
   PubMed Web of Science ®Google Scholar
• Hamberg, M., Israelsson, U. and Samuelsson, B. (1971) "Metabolism of prostaglandins", Ann. NY Acad. Sci. 180, 138–163.
   Google Scholar
• Samuelsson, B., Granström, E., Green, K., Hamberg, M. and Hammarström, S. (1975) "Prostaglandins", Ann. Rev. Biochem. 44, 669–695.
   PubMed Web of Science ®Google Scholar
• Basu, S. (1997) "Metabolism of 8-iso-PGF2e, in the rabbit", Prostaglandins Leukot. Essent. Fatty Acids 57, 267.
   Google Scholar
• Anggárd, E., Larsson, C. and Samuelsson, B. (1971) "The distribution of 15-hydroxy dehydrogenase and prostaglandin -A13 reductase in tissues of the swine", Acta Physiol. Scand. 81, 391–404.
   Google Scholar
• Basu, S., Sjiiquist, B., Resul B. and Stjernschantz, J. (1992) "Presence of a 15-ketoprostaglandin A13-reductase in the porcine cornea", Acta Chem. Scand. 46, 108–110.
   PubMedGoogle Scholar
• Basu, S. and Stjernschantz, J. (1997) "A13-Reductase dependent metabolism of prostaglandins in the mammalian brain and eye", Prostaglandins Leukot. Essent. Fatty Acids 57, 305–310.
   PubMed Web of Science ®Google Scholar
• Halliwell, B. (1994) "Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?", Lancet 10, 721–724.
   Google Scholar
• Halliwell, B. and Gutteridge, J.M.C. (1999) Free Radical Biology and Medicin, 3rd Ed. (Oxford University Press, New York).
   Google Scholar
• Halliwell, B. and Grootveld, M. (1987) "The measurement of free radical reactions in humans. Some thoughts for human experimentation", FEBS Lett. 213, 9–14.
   PubMed Web of Science ®Google Scholar
• Cracowski, J.-L., Durand, T. and Bessard, G. (2002) "Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical appli-cations", Trends Pharmacol. Sci. 135, 360–366.
   Google Scholar
• Lawson, J.A., Rokach, J. and FitzGerald, G.A. (1999) "Isoprostanes: formation analysis and use of indicies of lipid peroxidation in vivo", J. Biol. Chem. 27, 24441–24444.
   Google Scholar
• Morrow, J.D. (1992) "Formation of novel non-cyclooxygen-ase-derived prostanoids (F2-isoprostanes) in CC14 hepato-toxicity", J. Clin. Investig. 90, 2502–2507.
   PubMed Web of Science ®Google Scholar
• Basu, S. (1999) "Oxidative injury induced cyclooxygenase activation in experimental hepatotoxicity", Biochem. Biophys. Res. Commun. 254, 764–767.
   PubMed Web of Science ®Google Scholar
• Södergren, E., Cederberg, J., Vessby, B. and Basu, S. (2001) "Vitamin E reduces lipid peroxidation in experimental hepatotoxicity in rats", Fur. J. Nutr. 40, 10–16.
   Google Scholar
• Richelle, M., Turini, ME., Guidoux, R., Tavazzi, I., Metairon, S. and Fay, LB. (1999) "Urinary isoprostane excretion is not confounded by the lipid content of diet", FEBS Lett. 459, 259–262.
   PubMed Web of Science ®Google Scholar
• Gopaul, N.K., Halliwell, B. and Anggird, E.E. (2000) "Measurement of plasma F2-isoprostanes as index of lipid peroxidation does not appear to be confounded by diet", Free Radic. Res. 33, 115–117.
   PubMed Web of Science ®Google Scholar
• Södergren, E., Cederberg, J., Basu, S. and Vessby, B. (1999) "Vitamin E supplementation decreases basal levels of F2-isoprostanes and prostaglandin F2,,, in rats", J. Nutr. 130, 10–14.
   Google Scholar
• Ghosal, A.K. and Recknagel, R.O. (1965) "Positive evidence of acceleration of lipid peroxidation in rat liver by carbon tetrachloride: in vitro experiments", Life Sci. 4, 1521–1530.
   Google Scholar
• Comporti, M., Saccocci, C. and Dianzani, MB. (1965) "Effect of CC14 in vitro and in vivo on lipid peroxidation of rat liver homogenates and subcellular fractions", Enzymologia 29, 185–204.
   PubMedGoogle Scholar
• Glende, E.A., Jr., Hruszkewycz, A.M. and Recknagel, R.O. (1976) "Critical role of lipid peroxidation in carbon tetrachloride-induced loss of aminopyrine demethylase, cytochrome P-450 and glucose-6-phosphatase", Biochem. Pharmacol. 25, 2163–2170.
   PubMedGoogle Scholar
• Ingall, A., Lott, K.A. and Slater, T.F. (1978) "Metabolic activation of carbon tetrachloride to a free-radical product: studies using a spin trap", Biochem. Soc. Trans. 6, 962–978.
   PubMedGoogle Scholar
• Basu, S. (2003) "Carbon tetrachloride induced lipid peroxidation: eicosanoid formation and its regulation by antioxidants", Toxicology 189, 113–127.
   PubMed Web of Science ®Google Scholar
• Södergren, E., Vessby, B. and Basu, S. (2000) "Radio-immunological measurement of F2-isoprostanes after hydrolysis of lipids in tissues", Prostaglandins Leukot. Essent. Fatty Acids 63, 149–152.
   PubMed Web of Science ®Google Scholar
• Halliwell, B. (2000) "Lipid peroxidation, antioxidants and cardiovascular disease: how should we move forward", Cardiovasc. Res. 18, 410–418.
   Google Scholar
• Wang, Z., Ciabattoni, G., Creminon, C., Lawson, J., Fitzgerald, G.A., Patrono, C. and Maclouf, J. (1995) "Immunological characterization of urinary 8-epi-prosta-glandin F2,„ excretion in man", J. Pharmacol. Exp. Ther. 275, 94–100.
   PubMed Web of Science ®Google Scholar
• Pratico, D., Barry, OP., Lawson, J.A., Adiyaman, M., Hwang, S.W., Khanapure, S.P., Iuliano, L., Rokach, J. and FitzGerald, GA. (1998) "1PF2..-I: an index of lipid per-oxidation in humans", Proc. Natl Acad. Sci. USA 95, 3449–3454.
   PubMed Web of Science ®Google Scholar
• Helmersson, J. and Basu, S. (1999) "8-iso-PGF2,„ excretion rate and diurnal variation in urine in normal subjects", Prostaglandins Leukot. Essent. Fatty Acids 61, 203–205.
   PubMed Web of Science ®Google Scholar
• Basu, S., Smedman, A. and Vessby, B. (2000) "Conjugated linoleic acid induces lipid peroxidation in humans", FEBS Lett. 468, 33–36.
   PubMed Web of Science ®Google Scholar
• Helmersson, J. and Basu, S. (2001) "F2-Isoprostane and prostaglandin F2,, metabolite excretion rate and day to day variation in healthy humans", Prostaglandins Leukot. Essent. Fatty Acids 65, 99–102.
   PubMed Web of Science ®Google Scholar
• Mutschler, D.K., Eriksson, M.B., Wikström, B.G., Lind, L., Larsson, A., Bergren-Kiiski, R., Lagrange, A., Nordgren, A. and Basu, S. (2003) "Microdialysis-evaluated myocardial COX-mediated inflammation and early circulatory depression in porcine endotoxemia", Crit. Care Med. 31, 1780–1785.
   PubMedGoogle Scholar
• Takahashi, K., Nammour, T.M., Fukunaga, M., Ebert, J., Morrow, J.D., Roberts, L.J., II, Hoover, R.L. and Badr, K.F. (1992) "Glomerular action of a free radical generated novel prostaglandin, 8-epi-prostaglandin F2, Evidence for inter-actions with thromboxane A2 receptors", J. Clin. Investig. 90, 131–141.
   Google Scholar
• Banerjee, M., Kang, K.H., Morrow, J.D., Roberts, L.J. and Newman, J.H. (1992) "Effect of a novel prostaglandin, 8-epi-PGF2,„ in rabbit lung in situ", Am. J. Physiol. 263, H660—H663.
   Google Scholar
• Bernareggi, M., Rossoni, G. and Berti, F. (1998) "Broncopulmonary effects of 8-epi-PGF2A in anaesthesized guinea pigs", Pharmacol. Res. 37, 75–80.
   PubMedGoogle Scholar
• Wagner, R.S., Weare, C., Jin, N., Mohler, E.R. and Rhoades, R.A. (1997) "Characterization of signal transduc-tion events stimulated by 8-epi-prostaglandin (PG) F2 alpha in rat aortic rings", Prostaglandins 54, 581–599.
   PubMedGoogle Scholar
• Lahaie, I., Hardy, P., Hou, X., Hassessian, H., Asselin, P., Lachapelle, P., Almazan, G., Varma, DR., Morrow, J.D., Roberts,L.J., II and Chemtob, S. (1998) "A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2 alpha on retinal vessels", Am. J. Physiol. 274, R1406—R1416.
   Google Scholar
• Hoffman, S.W., Moore, S. and Ellis, E.F. (1997) "Isoprostanes: free radical-generated PGs with constrictor effects on cerebral arteries", Stroke 28, 844–849.
   PubMed Web of Science ®Google Scholar
• Sarabi, M., Vessby, B., Basu, S. and Lind, L. (1999) "Relationship between endothelium-dependent vasodila-tion and serum vitamin E and plasma 8-iso-PGF2,„ levels in healthy subjects", J. Vasc. Res. 36, 486–491.
   PubMedGoogle Scholar
• Longmire, A.W., Roberts, L.J. and Morrow, J.D. (1994) "Actions of the E2-isoprostane, 8-iso-PGE2, on the platelet thromboxane/endoperoxide receptor in humans and rats: Additional evidence for the existence of a unique isoprostane receptor", Prostaglandins 48, 247–256.
   PubMedGoogle Scholar
• Basu, S. (2003) "F2-Isoprostane induced formation of prostaglandin F2,,, in the rabbit", Free Radic. Res. Abs. 37, 79.
   Google Scholar
• Roberts, L.J., II, Montine, T.J., Markesbery, W.R., Tapper, A.R., Hardy, P., Chemtob, S., Dettbarn, W.D. and Morrow, J.D. (1998) "Formation of isoprostane-like com-pounds (neuroprostanes) in vivo from docosahexaenoic acid", J. Biol. Chem. 273, 13605–13612.
   Google Scholar
• Meagher, E.A., Barry, 0.E, Burke, A., Lucey, M.R., Lawson, J.A., Rokach, J. and FitzGerald, G.A. (1999) "Alcohol induced generation of lipid peroxidation products in humans", J. Clin. Investig. 104, 805–813.
   PubMedGoogle Scholar
• Aleynik, S.I., Leo, M.A., Ma, X., Aleynik, M.K. and Lieber, C.S. (1997) "Polyenylphosphatidyl choline prevents carbon tetrachloride-induced lipid peroxidation while it attenuates liver fibrosis", J. Hepatol. 27, 554–561.
   PubMed Web of Science ®Google Scholar
• Morrow, J.D., Frei, B., Longmire, A.W., Gaziano, J.M., Lynch, S.M., Shyr, Y., Strauss, W.E., Oates, J.A. and Roberts, L.J., II (1995) "Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers", N. Engl. J. Med. 332, 1198–1203.
   PubMed Web of Science ®Google Scholar
• Reilly, M., Delanty, N., Lawson, J.A. and FitzGerald, G.A. (1996) "Modulation of oxidant stress in vivo in chronic cigarette smokers", Circulation 94, 19–25.
   PubMed Web of Science ®Google Scholar
• Sinzinger, H. (2000) "Eicosanoid production and lymphatic responsiveness in human cigarette smokers compared to non-smokers", Lymphology 33, 24–31.
   PubMed Web of Science ®Google Scholar
• Montuschi, P., Collins, J.V., Ciabattoni, G., Lazzeri, N., Corradi, M., Kharitonov, S.A. and Barnes, P.J. (2000) "Exhaled 8-isoprostane as in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers", Am. J. Respir. Crit. Care Med. 162, 1175–1177.
   PubMed Web of Science ®Google Scholar
• Oguogho, A., Lupattelli, G., Palumbo, B. and Sinzinger, H. (2000) "Isoprostanes quickly normalize after quitting cigarette smoking", Vasa 29, 103–105.
   PubMed Web of Science ®Google Scholar
• Chehne, F., Oguogho, A., Lupattelli, G., Budinsky, A.C., Palumbo, B. and Sinzinger, H. (2001) "Increase of isoprostane 8-epi-PGF2", Prostaglandins Leukot. Essent. Fatty Acids 64, 307–310.
   PubMed Web of Science ®Google Scholar
• Helmersson, J., Mattsson, P. and Basu, S. (2002) "F2-Iso-prostane and prostaglandin F2,, metabolite levels in man with migraine", Clin. Sci. (London) 102,39–43.
   PubMed Web of Science ®Google Scholar
• Ide, T., Tsutsui, H., Ohashi, N., Hayashidani, S., Suematsu, N., Tsuchihashi, M., Tamai, H. and Takeshita, A. (2002) "Greater oxidative stress in healthy young men compared with premenopausal women", Arterioscler. Thromb. Vasc. Biol. 22, 438–442.
   PubMed Web of Science ®Google Scholar
• Basu, S., Michaelsson, K., Olofsson, H., Johansson, S. and Melhus, H. (2001) "Association between oxidative stress and bone mineral density", Biochem. Biophys. Res. Commun. 288, 275–279.
   PubMed Web of Science ®Google Scholar
• Basu, S., Whiteman, M., Mattey, Di. and Halliwell, B. (2001) "Raised levels of F2-isoprostanes and prostaglandin F2,, in different rheumatic diseases", Ann. Rheum. Dis. 60, 627–631.
   PubMed Web of Science ®Google Scholar
• Cracowski, J.L., Marpeau, C., Carpentier, P.H., Imbert, B., Hunt, M., Stanke-Labesque, E and Bessard, G. (2001) "Enhansed in vivo lipid peroxidation in scleroderma spectrum disorders", Arthritis Rheum. 44, 1143–1148.
   PubMedGoogle Scholar
• Cracowski, J.L., Carpentier, P.H., Imbert, B., Cachot, S., Stanke-Labesque, E, Bessard, J. and Bessard, G. (2002) "Increased urinary F2-isoprostanes in systemic sclerosis but not in primary Raynaud's phenomenon. Effect of a cold exposure", Arthritis Rheum. 46, 1319–1323.
   PubMedGoogle Scholar
• Stein, CM., Tanner, S.B., Awad, J.A., Roberts, L.J., II and Morrow, J.D. (1996) "Evidence of free radical mediated injury (isoprostane overproduction) in scleroderma", Arthritis Rheum. 39, 1146–1150.
   PubMed Web of Science ®Google Scholar
• Montine, T.J., Beal, M.F., Cudkowicz, ME., O'Donnell, H., Margolin, R.A., McFarland, L., Bachrach, A.F., Zackert, Roberts, L.J. and Morrow, J.D. (1999) "Increased CSF F2-isoprostane concentration in probable AD", Neurology 52, 562–565.
   Google Scholar
• Montine, T.J., Beal, M.F., Robertson, D., Cudkowicz, ME., Biaggioni, I., O'Donnell, H., Zackert, W.E., Roberts, L.J. and Morrow, J.D. (1999) "Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease", Neurology 52, 1104–1105.
   Google Scholar
• Montine, T.J., Markesbery, W.R., Zackert, W., Sanchez, S.C., Roberts, L.J., II and Morrow, J.D. (1999) "The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with the density of the neuritic plaques and neorofibrillary tangles or with APOE genotype in Alzheimer's disease patients", Am. J. Pat hol. 155, 863–868.
   PubMed Web of Science ®Google Scholar
• Pratico, D., My, L.V., Trojanowski, J.Q. and Fitzgerald, GA. (1998) "Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo", FASEB J. 12, 1777–1783.
   PubMed Web of Science ®Google Scholar
• Feillet-Coudray, C., Tourtauchaux, R., Niculescu, M., Rock, E., Tauveron, I., Alexandre-Gouabau, MC., Rayssiguier, Y., Jalenques, I. and Mazur, A. (1999) "Plasma levels of 8-epi- PGF2„, an in vivo marker of oxidative stress, are not effected by aging or Alzheimer's disease", Free Radic. Biol. Med. 27, 463–469.
   PubMed Web of Science ®Google Scholar
• Montine, T.J., Shinobu, L., Montine, KS., Roberts, II, L.J., Kowall, NW., Beal, M.F. and Morrow, J.D. (2000) "No difference in plasma or urinary F2-isoprostanes among patients with Huntington's or Alzheimer's disease", Ann. Neurol. 48, 950.
   Google Scholar
• Monga, M., Dunn, K. and Rajasekaran, M. (2001) "Charac-terization of ultrastructural and metabolic abnormalities in semen from men with spinal cord injury", J. Spinal Cord Med. 24, 41–46.
   PubMedGoogle Scholar
• Montuschi, P., Corradi, M., Ciabattoni, G., Nightingale, J., Kharitonov, S.A. and Barnes, P.J. (1999) "Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients", Am. J. Respir. Crit. Care Med. 160, 216–220.
   PubMed Web of Science ®Google Scholar
• Wood, L.G., Fitzgerald, D.A., Gibson, P.G., Cooper, D.M. and Garg, M.L. (2000) "Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma", Lipids 35, 967–974.
   PubMed Web of Science ®Google Scholar
• Montuschi, P., Ciabattoni, G., Paredi, P., Pantelidis, P., du Bois, R.M., Kharitonov, S.A. and Barnes, P.J. (1998) "8-isoprostane as biomarker of oxidative stress in interstial lung diseases", Am. J. Respir. Crit. Care Med. 158, 1524–1527.
   PubMed Web of Science ®Google Scholar
• Collins, C.E., Quaggiotto, P., Wood, L., O'Loughlin, E.V., Henry, R.L. and Garg, M.L. (1999) "Elevated plasma levels of F2-isoprostane in cystic fibrosis", Lipids 34, 551–572.
   Google Scholar
• Ciabattoni, G., Davi, G., Collura, M., Iapichino, L., Pardo, E, Ganci, A., Romagnoli, R., Madouf, J. and Patrono, C. (2000) "In vivo lipid peroxidation and platelet activation in cystic fibrosis", Am. J. Respir. Crit. Care Med. 162, 1195–1201.
   PubMed Web of Science ®Google Scholar
• Montuschi, E, Kharitonov, S.A., Ciabattoni, G., Corradi, M., van Rensen, L., Geddes, D.M., Hodson, M.E. and Barnes, P.J. (2000) "Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis", Thorax 55, 205–209.
   PubMed Web of Science ®Google Scholar
• Cracowski, J.L., Cracowski, C., Bessard, G., Pepin, J.L., Bessard, J., Schwebel, C., Stanke-Labesque, F. and Pison, C. (2001) "Increased lipid peroxidation in patients with pulmonary hypertension", Am. J. Crit. Care Med. 164, 1248–1252.
   Google Scholar
• Klings, ES., Christman, B.W., McClung, J., Stucchi, A.F., McMahon, L., Brauer, M. and Farber, H.W. (2001) "Increased F2-isoprostanes in acute chest syndrome of sickle cell disease as a marker of oxidative stress", Am J. Respir. Crit. Care Med. 164, 1248–1252.
   PubMedGoogle Scholar
• Barden, A., Beilin, L.J., Ritchie, J., Croft, K.D., Walters, B.N. and Michael, CA. (1996) "Plasma and urinary 8-isoprostane as an indicator of lipid peroxidation in preeclampsia and normal pregnancy", Clin. Sci. (Lond.) 91, 711–718.
   PubMed Web of Science ®Google Scholar
• Walsh, S.W., Vaughan, J.E., Wang, Y. and Roberts, L.J., II (2000) "Placental isoprostane isoprostanes significantly increased in preeclampsia", FASEB J. 14, 1289–1296.
   PubMed Web of Science ®Google Scholar
• Morris, J.M., Gopaut N.K., Endresen, M.J., Knight, M., Linton, E.A., Dhir, S., Anggard, E.E. and Redman, C.W. (1998) "Circulating markers of oxidative stress raised in normal pregnancy and pre-eclampsia", Br. J. Obstet. Gynaecol. 105, 1195–1199.
   PubMedGoogle Scholar
• Regan, CL., Levine, R.J., Baird, D.D., Ewell, M.G., Martz, K.L., Sibai, B.M., Rokach, J., Lawson, J.A. and Fitzgerald, G.A. (2001) "No evidence for lipid peroxidation in severe preeclampsia", Am. J. Obstet. Gynaecol. 185, 572–578.
   PubMed Web of Science ®Google Scholar
• Basu, S., Hayashi, M., Nitta, R., Kobayashi, K., Takeda, K. and Ishihara, 0. (2002) "Levels of lipid peroxidation products and antioxidants in preeclampsia, normal preg-nancy and nonpregnancy", Free Radic. Biol. Med. 33(2), 409.
   Google Scholar
• Pratico, D., Iuliano, L., Mauriello, A., Spagnoli, L., Lawson, J.A., Rokach, J., Maclouf, J., Violi, F. and FitzGerald, GA. (1997) "Localisation of distinct F2-isoprostanes in human atherosclerotic lesions", J. Clin. Investig. 100, 2028–2034.
   PubMed Web of Science ®Google Scholar
• Gniwotta, C., Morrow, J.D., Roberts, II, L.J. and Kuhn, H. (1997) "Prostaglandin F2e, like compounds, F2-isoprostanes are present in increased amounts in human atherosclerotic lesions", Arterioscler. Thromb. Vasc. Biol. 17, 2975–2981.
   PubMedGoogle Scholar
• Mehrabi, MR., Ekmekcioglu, C., Tatzber, F., Oguogho, A., Ulrich, R., Morgan, A., Tamaddon, F., Grimm, M., Glogar, H.D. and Sinzinger, H. (1999) "The isoprostane, 8-epi-F2,„ is accumulated in coronary arteries isolated from patients with coronary heart disease", Cardiovasc. Res. 43, 492–499.
   PubMed Web of Science ®Google Scholar
• Cipollone, F., Ciabattoni, G., Patrignani, P., Pasquale, M., Di Gregorio, D., Bucciarelli, T., Davi, G., Cuccurullo, F. and Patrono, C. (2000) "Oxidant stress and aspirin insensitive thromboxane biosynthesis in severe unstable angina", Circulation 102, 1007–10013.
   PubMed Web of Science ®Google Scholar
• Delanty, N., Reilly, M.P., Pratico, D., Lawson, J.A., McCarthy, J.F., Wood, A.E., Ohnishi, ST., Fitzgerald, D.J. and FitzGerald, GA. (1997) "8-epi-PGF2e, generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo", Circulation 95, 2492–2499.
   PubMed Web of Science ®Google Scholar
• Ulus, AT., Aksoyek, A., Ozkan, M., Katircioglu, S.F. and Basu, S. (2003) "Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans", Free Radic. Biol. Med. 34, 911–917.
   PubMed Web of Science ®Google Scholar
• Reilly, M.P., Delanty, N., Roy, L., Rokach, J., Callaghan, P.O., Crean, P., Lawsonm, J.A. and FitzGerald, GA. (1997) "Increased formation of the isoprostanes IPF4 and 8-epi-prostaglandin F2e, in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans", Circulation 96, 3314–3320.
   PubMed Web of Science ®Google Scholar
• Iuliano, L., Pratico, D., Greco, C., Mangieri, E., Scibilia, G., FitzGerald, G.A. and Violi, E (2001) "Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA", J. Am. Coll. Cardiol. 37, 76–80.
   PubMedGoogle Scholar
• Mallat, Z., Philip, I., Lebret, M., Chatel, D., Maclouf, J. and Tedgui, A. (1998) "Elevated levels of 8-iso-prostaglandin F2,,, in pericardial fluid of patients with heart failure: a potential role for in vivo oxidant stress in ventricular dilatation and progression to heart failure", Circulation 97, 1536–1539.
   PubMed Web of Science ®Google Scholar
• Cracowski, J.L., Tremel, F., Marpeau, C., Baguet, J.P., Stanke-Labesque, F., Manion, J.M. and Bessard, G. (2000) "Increased formation of F2-isoprostanes in patients with severe heart failure", Heart 84, 439–440.
   PubMed Web of Science ®Google Scholar
• Gopaut N.K., Anggard, E.E., Mallet, Al., Betteridge, D.J., Wolff, S.P. and Nourooz-Zadeh, J. (1995) "Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus", FEBS Lett. 17, 225–229.
   Google Scholar
• Davi, G., Ciabattoni, G., Consoli, A., Mezzetti, A., Falco, A., Santarone, S., Pennese, E., Vitacolonna, E., Bucciarelli, T., Costantini, E, Capani, F. and Patrono, C. (1999) "In vivo formation of 8-epi-PGF2e, and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation", Circulation 99, 224–229.
   PubMed Web of Science ®Google Scholar
• Murai, Y., Hishinuma, T., Suzuki, N., Satoh, J., Toyota, T. and Mizugaki, M. (2000) "Determination of 8-epi prostaglandin F (2alpha) using liquid chromatography-tandem mass spectrometry: increased excretion in diabetics", Prosta-glandins Other Lipid Mediat. 62, 173–181.
   PubMed Web of Science ®Google Scholar
• Helmersson, J., Vessby, B. and Basu, S. (2002) "Inflammation and oxidative injury in elderly men with type 2 diabetes", Free Radic. Biol. Med. 33(2), S344.
   Google Scholar
• Vessby, J., Basu, S., Mohsen, R., Berne, C. and Vessby, B. (2002) "Oxidative stress and antioxidant status in Type 1 diabetes mellitus", J. Intern. Med. 251, 69–76.
   PubMed Web of Science ®Google Scholar
• O'Byrne, S., Forte, P., Roberts, L.J., II, Morrow, J.D., Johnston, A., Anggard, E., Leslie, R.D. and Benjamin, N. (2000) "Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion", Diabetes 49, 857–862.
   PubMed Web of Science ®Google Scholar
• Nanji, A.A., Khwaja, S., Tahan, S.R. and Sadrzadeh, S.M. (1994) "Plasma levels of a novel noncyclooxygenase-derived prostanoid (8-isoprostane) correlate with severity of liver injury in experimental alcoholic liver disease", J. Pharmacol. Exp. Ther. 269, 1280–1285.
   PubMed Web of Science ®Google Scholar
• McCord, J.M. (1985) "Oxygen-derived free radicals in post ischemic tissue injury", N. Engl. J. Med. 312, 159–163.
   PubMed Web of Science ®Google Scholar
• McCord, J.M. (1987) "Oxygen-derived radicals: a link between reperfusion injury and inflammation", Fed. Proc. 46, 2402–2406.
   PubMedGoogle Scholar
• Basu, S., Hellberg, A., Ulus, AT., Westman, J. and Karacagil, S. (2001) "Biomarkers of free radical injury during spinal cord ischemia", FEBS Lett. 508, 36–38.
   PubMed Web of Science ®Google Scholar
• Basu, S., Nozari, A., Liu, XL., Rubertsson, S. and Wiklund, L. (2000) "Development of a novel biomarker of free radical damage in reperfusion injury after cardiac arrest", FEBS Lett. 470, 1–6.
   PubMed Web of Science ®Google Scholar
• Basu, S., Liu, X., Nozari, A., Rubertsson, S., Miclescu, A. and Wiklund, L. (2003) "Evidence for time-dependent maximum increase of free radical damage and eicosanoid formation in the brain as related to duration of cardiac arrest and cardio-pulmonary resuscitation", Free Radic. Res. 37, 251–256.
   PubMed Web of Science ®Google Scholar
• Liu, X.L., Nozari, A., Basu, S., Ronquist, G., Rubertsson, S. and Wiklund, L. (2002) "Neurological outcome after experimental cardiopulmonary resuscitation: a result of delayed and potentially treatable neuronal injury?", Acta Anaesthesiol. Scand. 46, 537–546.
   PubMed Web of Science ®Google Scholar
• Liu, XL., Wiklund, L., Nozari, A., Rubertsson, S. and Basu, S. (2003) "Differences in cerebral reperfusion and oxidative injury after cardiac arrest in pigs", Acta Anaesthesiol. Scand. 47, 958–967.
   PubMed Web of Science ®Google Scholar
• Basu, S. and Eriksson, M. (1998) "Oxidative injury and survival during endotoxemia", FEBS Lett. 438, 159–160.
   PubMed Web of Science ®Google Scholar
• Basu, S. and Eriksson, M. (2000) "Lipid peroxidation induced by an early inflammatory response in endo-toxemia", Acta Anaesthesiol. Scand. 44, 17–23.
   PubMed Web of Science ®Google Scholar
• Basu, S. and Eriksson, M. (2000) "Vitamin E in relation to lipid peroxidation in experimental septic shock", Prostaglandins Leukot. Essent. Fatty Acids 62, 195–199.
   PubMedGoogle Scholar
• Scholz, H., Yndestad, Damás, T., Tonstad, S., Aukrust, P. and Halvorsen, P. (2003) "8-Isoprostane increases expression of interleuldn-8 in human macrophages through activation of mitogen-activated protein lcinases", Cardiovasc. Res. 59, 945–954.
   PubMedGoogle Scholar
• Sentman, M.L., Brännstrom, T., Westerlund, S., Laukkanen, M.O., Yla-Herttuala, S., Basu, S. and Marklund, S.L. (2001) "Extracellular superoxide dismutase deficiency and atherosclerosis in mice", Arterioscler. Thromb. Vasc. Biol. 21, 1477–1482.
   PubMed Web of Science ®Google Scholar
• Cederberg, J., Basu, S. and Eriksson, U.J. (2001) "Increased rate of lipid peroxidation and carbonylation in experimental diabetic pregnancy", Diabetologia 44, 766–774.
   PubMed Web of Science ®Google Scholar
• Awad, J.A., Morrow, J.D., Hill, K.E., Roberts, I.I.L.J. and Burk, R.F. (1994) "Detection and localization of lipid peroxidation in selenium- and vitamin E-deficient rats using F2-isoprostanes", J. Nutr. 124, 810–816.
   PubMed Web of Science ®Google Scholar
• Burk, R.F., Hill, K.E., Awad, J.A., Morrow, J.D., Kato, T., Cockell, K.A. and Lyons, P.R. (1995) "Pathogenesis of diquat-induced liver liver necrosis in selenium-deficient rats: assessment of the roles of lipid peroxidation and seleno protein", Hepatology 21, 561–569.
   PubMed Web of Science ®Google Scholar
• Becker, P.M., Sanders, SE, Price, P. and Christman, B.W. (1998) "F2-isoprostane generation in isolated ferret lung after oxidant injury or ventilated ischemia", Free Radic. Biol. Med. 25, 703–711.
   PubMed Web of Science ®Google Scholar
• Freese, R., Basu, S., Heitanen, E., Nair, J., Burtsch, H. and Mutanen, M. (1999) "Green tea extract decreases plasma malondialdehyde concentration but does not affect other indicators of oxidative stress, nitric oxide production, or hemostatic factors during a high-linoleic acid diet in healthy females", Fur. J. Nutr. 38, 149–157.
   Google Scholar
• Dragstedt, L.O., Pedersen, A., Hermetter, A., Basu, S., Hansen, S., Ravn-Haren, G., Ka11, M., Breinholt, V., Castenmiller, J., Stagsted, J., Jakobsen, J., Skibsted, L.H., Loft, S.E. and the late Sandstrom, B. (2003) "The 6-a-day study: effects of fruits and vegetables on markers of oxidative stress and defence in healthy non-smokers", Am. J. Clin. Nutr., (Final submission).
   Google Scholar
• Freese, R., Alfthan, G., Jauhiainen, M., Basu, S., Erlund, I., Salminen, I., Aro, A. and Mutanen, M. (2002) "High intakes of vegetables, berries and apple combined with high intake of linoleic acid or oleic acid only slightly effect markers of lipid peroxidation or lipoprotein metabolism in healthy subjects", Am. J. Clin. Nutr. 76, 950–960.
   PubMed Web of Science ®Google Scholar
• Visioli, F., Caruso, D., Galli, C., Viappiani, S., Galli, G. and Sala, A. (2000) "Olive oil rich in natural catecholic phenols decrease isoprostane excretion in humans", Biochem. Biophys. Res. Commun. 278, 797–799.
   PubMed Web of Science ®Google Scholar
• Higdon, J.V., Liu, J., Du, S.H., Morrow, J.D., Ames, B.N. and Wander, R.C. (2000) "Supplementation of postmeno-pausal women with fish oil rich in eicosapentanoic acid and docosahexanoic acid is not associated with greater in vivo lipid peroxidation compared with oils rich in oleates and linoleate as assessed by plasma malon-dialdehyde and F2-isoprostanes", Am. J. Clin. Nutr. 72, 714–722.
   PubMed Web of Science ®Google Scholar
• Mori, T.A., Dunstan, D.W., Burke, V, Croft, K.D., Rivera, J.H., Beilin, L.J. and Puddey, I.B. (1999) "Effect of dietary fish and exercise training on urinary F2-isoprostane excretion in non-insulin-dependent diabetic patients", Metabolism 48, 1402–1408.
   PubMed Web of Science ®Google Scholar
• Turpeinen, A.M., Basu, S. and Mutanen, M. (1998) "A high linoleic acid diet increases oxidative stress in vivo and affects nitric oxide metabolism in humans", Prostaglandins Leukot. Essent. Fatty Acids 59, 229–233.
   PubMedGoogle Scholar
• Basu, S., Riserus, U., Turpeinen, A. and Vessby, B. (2000) "Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity", Clin. Sci. (Lond.) 99, 511–516.
   PubMed Web of Science ®Google Scholar
• Riserus, U., Basu, S., Jovinge, S., Fredrikson, G.N., Arnlov, J. and Vessby, B. (2002) "Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein. A potential link to fatty acid-induced insulin resistance", Circulation 106, 1925–1929.
   PubMed Web of Science ®Google Scholar
• Smedman, A., Vessby, B. and Basu, S. (2004) "Isomer specific effects of conjugated linoleic acid on lipid peroxidation in humans. Regulation by Alpha Tocopherol and Cyclo-oxygenase-2 inhibitor", Clin. Sci. (Lond.) 106, 67–73.
   PubMed Web of Science ®Google Scholar
• Turpeinen, A.M., Mutanen, M., Salminen, I., Basu, S., Palmquist, D.L. and Griinary, M.J. (2002) "Bioconversion of vaccenic acid to conjugated linoleic acid in humans", Am. J. Clin. Nutr. 76, 504–510.
   PubMed Web of Science ®Google Scholar
• Meagher, E.A., Barry, OP., Lawson, J.A., Rokach, J. and FitzGerald, G.A. (2001) "Effects of vitamin E on lipid peroxidation in healthy persons", J. Am. Med. Assoc. 285, 1178–1182.
   PubMed Web of Science ®Google Scholar
• Levine, M., Wang, Y., Padayatty, S.J. and Morrow, J. (2001) "A new recommended dietary allowance of vitamin C for healthy young women", Proc. Natl Acad. Sci. USA 98, 9842–9846.
   PubMed Web of Science ®Google Scholar
• Patrignani, P., Panara, M.R., Tacconelli, S., Seta, F., Bucciarelli, T., Ciabattoni, G., Alessandrini, P., Mezzetti, A., Santini, G., Sciulli, M.G., Cipollone, F., Davi, G., Gallina, P., Bon, G.B. and Patrono, C. (2000) "Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers", Circulation 102, 539–545.
   PubMed Web of Science ®Google Scholar
• Weinberg, R.B., VanderWerken, B.S., Anderson, R.A., Stegner, J.E. and Thomas, J. (2001) "Pro-oxidant effect of vitamin E in cigarette smokers consuming a high polyunsaturated fat diet", Arterioscler. Thromb. Vasc. Biol. 21, 1029–1033.
   PubMed Web of Science ®Google Scholar
• Roberts, L.J., II, Oates, J.A., Fazio, S., Gross, M.D., Linton, M.F. and Morrow, J.D. (2002) "A-Tocopherol supplementation reduces F2-isoprostane concentrations in hypercholessterolemic humans only at doses of 800 IU or higher", Free Radic. Biol. Med. 33(2), 412.
   Google Scholar
• Davi, G., Alessandrini, P., Mezzetti, A., Minotti, G., Bucciarelli, T., Costantini, E, Cipollone, F., Bon, G.B., Ciabattoni, G. and Patrono, C. (1997) "In vivo formation of 8-epi-prostaglandin F2a is increased in hypercholestero-mia", Arterioscler. Thromb. Vasc. Biol. 17, 3230–3235.
   PubMed Web of Science ®Google Scholar
• Davi, G., Di Minno, G., Coppola, A., Andria, G., Cerbone, A.M., Madonna, P., Tufano, A., Falco, A., Marchesani, P., Ciabattoni, G. and Patrono, C. (2001) "Oxidative stress and platelet activation in homozygous homocystinuria", Circulation 104, 1124–1128.
   PubMed Web of Science ®Google Scholar
• Pratico, D., Iuliano, L., Basili, S., Ferro, D., Camastra, C., Cordova, C., FitzGerald, GA. and Violi, F. (1998) "Enhansed lipid peroxidation in hepatic cirrhosis", J. Investig. Med. 46, 51–57.
   PubMed Web of Science ®Google Scholar
• Pratico, D., Tangirala, R.K., Rader, D.J., Rokach, J. and FitzGerald, GA. (1998) "Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice", Nat. Med. 4, 1189–1192.
   PubMed Web of Science ®Google Scholar
• Aleynik, S.I., Leo, MA., Aleynik, M.K. and Lieber, C.S. (1998) "Increased circulating products of lipid peroxidation in patients with alcoholic liver disease", Alcohol. Clin. Exp. Res. 22, 192–196.
   PubMed Web of Science ®Google Scholar
• Basu, S. and Eriksson, M. (2000) "Retinol palmitate counteracts oxidative injury during experimental septic shock", Annals Acad. Sci. (Singapore) 30, 265–269.
   Google Scholar
• Basu, S., Mutschler, D.K., Larsson, A.O., Kiiski, R., Nordgren, A. and Eriksson, M.B. (2001) "Propofol (Dipri-van-EDTA) counteracts oxidative injury and deterioration of the arterial oxygen tension during experimental septic shock", Resuscitation 50, 341–348.
   PubMed Web of Science ®Google Scholar
• Eriksson, M., Basu, S., Larsson, A., Mattsson, C., Eriksson, 0., Kiiski, R. and Nordgren, A. (2000) "Effects of melagatran, a novel direct thrombin inhibitor, during experimental septic shock", Expert Opin. of Investig. Drugs 9, 1129–1137.
   PubMedGoogle Scholar
• Pratico, D., Clark, C.M., Lee, V.M., Trojanowski, J.Q., Rokach, J. and FitzGerald, G.A. (2000) "Increased 8,12-iso-iPF2,,,-VI in Alzheimer's disease: correlation of a non-invasive index of lipid peroxidation with disease severity", Ann. Neurol. 48, 809–812.
   PubMed Web of Science ®Google Scholar
• Raal, F.J., Pilcher, G.J., Waisberg„ R., Philani Buthelezi, E., Veller, M.G. and Joffe, B.I. (1999) "Low-density lipoprotein cholesterol bulk is the pivotal determinant of atherosclerosis in familial hypercholesterolemia", Am. J. Cardiol. 83, 1330–1333.
   Google Scholar
• Berg, K., Wiseth, R., Basu, S., Skarra, S., Bjerve, K., Gunnes, S., Brurok, H. and Jynge, P. (2003) "Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography. A comparison of blood-borne isoprostane and troponin release", Free Radic. Biol. Med. Abs. 35, S130.
   Google Scholar
• Reilly, ME, Pratico, D., Delanty, N., DiMinno, G., Tremoli, E., Rader, D., Kapoor, S., Rokach, J., Lawson, J. and FitzGerald, G.A. (1998) "Increased formation of distinct F2 isoprostanes in hypercholesterolemia", Circulation 98, 2822–2828.
   PubMed Web of Science ®Google Scholar
• Cracowski, J.L., Ploin, D., Bessard, J., Baguet, J.P., Stanke-Labesque, F., Mallion, J.M., Bost, M. and Bessard, G. (2001) "Formation of isoprostanes in children with type Ha hypercholesterolemia", J. Cardiovasc. Pharmacol. 38, 13381–13386.
   Google Scholar
• Carpenter, C.T., Price, P.V. and Christman, B.W. (1998) "Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS", Chest 114, 1653–1659.
   PubMed Web of Science ®Google Scholar
• Montuschi, P., Collins, J.V., Ciabattoni, G., Lazzeri, N., Corradi, M., Kharitonov, S.A. and Barnes, P.J. (2000) "Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers", Am. J. Respir. Crit. Care Med. 162, 1175–1177.
   PubMed Web of Science ®Google Scholar
• Pratico, D., Basili, S., Vieri, M., Cordova, C., Violi, F. and Fitzgerald, G.A. (1998) "Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-BI, an index of oxidant stress", Am. J. Respir. Crit. Care Med. 158, 1709–1714.
   PubMed Web of Science ®Google Scholar
• Baraldi, E., Ghiro, L., Piovan, V, Carraro, S., Ciabattoni, G., Barnes, P.J. and Montuschi, E (2003) "Increased exhaled 8-isoprostane in childhood asthma", Chest 124, 25–31.
   PubMed Web of Science ®Google Scholar
• Davi, G., Chiarelli, F., Santilli, E, Pomilio, M., Vigneri, S., Falco, A., Basili, S., Ciabattoni, G. and Patrono, C. (2003) "Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration", Circulation 107, 3199–3203.
   PubMed Web of Science ®Google Scholar
• Hoeldtke, RD., Bryner, K.D., McNeill, DR., Warehime, S.S., Van Dyke, K. and Hobbs, G. (2003) "Oxidative stress and insulin requirements in patients with recent-onset type 1 diabetes", J. Clin. Endocrinol. Metab. 88, 1624–1628.
   PubMed Web of Science ®Google Scholar
• McKinney, E.T., Shouri, R., Hunt, R.S., Ahokas, R.A. and Sibai, B.M. (2000) "Plasma, urinary and salivary 8-epi-prostaglandin F2e, levels in normotensive and preeclamptic pregnancies", Am. J. Obstet. Gynecol. 183, 874–877.
   PubMed Web of Science ®Google Scholar
• Barden, A., Ritchie, J., Walters, B., Michael, C., Rivera, J., Mori, T., Croft, K. and Beilin, L. (2003) "Study of plasma factors associated with neutrophil activation and lipid peroxidation in preeclampsia", Hypertension 38, 803–808.
   Google Scholar
• Montine, T.J., Quinn, J.F., Milatovic, D., Silbert, L.C., Dang, T., Sanchez, S., Terry, E., Roberts, II, L.J., Kaye, J.A. and Morrow, J.D. (2003) "Peripheral F2-isoprostanes and F4-neuro-prostanes are not increased in Alzheimer's disease", Ann. Neurol. 52, 175–179.
   Google Scholar
• Fessel, J.P., Hulette, C., Powell, S., Roberts, L.J, II and Zhang, J. (2003) "Isofurans, but not F2-isoprostanes, are increased in the substantia nigra of patients with Parkinson's disease and with dementia with Lewy body disease", J. Neurochem. 85, 645–650.
   PubMed Web of Science ®Google Scholar
• Camphausen, K., Menard, C., Sproull, M., Goley, E., Basu, S. and Coleman, N. (2003) "Isoprostanes and prostaglandin F2a. levels in the urine of patients with prostate cancer prior to and during radiotherapy", J. Radiat. Oncol. Biol. Phys., (In press).
   Google Scholar
• Handelman, G.J., Walter, M.F., Adhikarla, R., Gross, J., Dallal, G.E., Levin, N.W. and Blumberg, J.B. (2001) "Elevated plasma F2-isoprostanes in patients on long-term hemo-dialysis", Kidney Int. 59, 1960–1966.
   PubMed Web of Science ®Google Scholar
• Hdzler, T.A., Morrow, J.D., Roberts, II, L.J., Evanson, J.A., Becker, B., Hakim, R.M., Shyr, Y. and Himmelfarb, J. (2002) "Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients", Clin. Nephrol. 58, 190–197.
   PubMedGoogle Scholar
• Cracowski, J.L., Souvignet, C., Quinn, N., Grosbois, X., Bayle, F., Stanke-Labesque, F., Vialtel, P. and Bessard, G. (2001) "Urinary F2-isoprostanes formation in kidney transplantation", Clin. Transplant. 15, 58–62.
   PubMed Web of Science ®Google Scholar
• Cracowski, J.L., Baguet, J.P., Ormezzano, 0., Bessard, J., Stanke-Labesque, F., Bessard, G. and Manion, J.M. (2003) "Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertension", Hypertension 41, 286–288.
   Google Scholar
• Gopaul, N.K., Manraj, M.D., Hebe, A., Lee Kwai Yan, S., Johnston, A., Carrier, M.J. and AnggArd, E.E. (2001) "Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism", Diabetologia 44, 706–712.
   PubMed Web of Science ®Google Scholar
• Spittle, MA., Hoenich, NA., Handelman, G.J., Adhikarla, R., Homel, E and Levin, NW (2001) "Oxidative stress and inflammation in hemodialysis patients", Am. J. Kidney Dis. 38, 1408–1413.
   PubMedGoogle Scholar
• Minuz, P., Patrignani, P., Gaino, S., Degan, M., Menapace, L., Tommasoli, R., Seta, F., Capone, ML., Tacconelli, S., Palatresi, S., Bencini, C., Del Vecchio, C., Mansueto, G., Arosio, E., Santonastaso, CL., Lechi, A., Morganti, A. and Patrono, C. (2003) "Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease", Circulation 106, 2800–2805.
   Google Scholar
• Morrow, J.D. and Roberts, L.J. (1994) "Mass spectrometry of prostanoids: F2-isoprostanes produced by non-cyclooxy-genase free radical-catalyzed mechanism", Methods Enzymol. 233, 163–174.
   PubMed Web of Science ®Google Scholar
• Morrow, J.D., Zackert, WE., Yang, J.P., Kurhts, E.H., Callewaert, D., Dworski, R., Kanai, K., Taber, D., Moore, K., Oates, J.A. and Roberts, L.J. (1999) "Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay", Anal. Biochem. 269, 326–331.
   PubMed Web of Science ®Google Scholar
• Nourooz-Zadeh, J., Gopaul, N.K., Barrow, S., Mallet, Al. and AnggArd, E.E. (1995) "Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: development of a solid-phase extraction procedure", J. Chromatogr. B. Biomed. Sci. Appl. 667, 199–208.
   PubMed Web of Science ®Google Scholar
• Bessard, J., Cracowski, J.L., Stanke-Labesque, E and Bessard, G. (2000) "Determination of isoprostaglandin F2alpha type DI in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassay", J. Chromatogr. B. Biomed. Sci. Appl. 754, 333–343.
   Google Scholar
• Walter, M.F., Blumberg, J.B., Dolnikowski, G.G. and Handelman, G.J. (2000) "Streamlined F2-isoprostane analysis in plasma and urine with high-performance chromatography and gas chromatography/mass spectroscopy", Anal. Chem. 280, 73–79.
   Google Scholar
• Burke, A., Lawson, J.A., Meagher, E.A., Rokach, J. and FitzGerald, G.A. (2000) "Specific analysis in plasma and urine of 2,3-dinor-5, 6-dihydro-isoprostane F(2alpha)-BI, a metabolite of isoprostane F(2alpha)-BI and an oxidation product of gamma-linolenic acid", J. Biol. Chem. 275, 2499–2504.
   PubMedGoogle Scholar
• Mori, TA., Croft, K.D., Puddey, I.B. and Beilin, L.J. (2001) "An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry", Anal. Biochem. 268, 117–125.
   Google Scholar
• Parker, CT., Graham, LB., Nguyen, UN., Gladen, B.C., Kadiiska, MB., Barrett, J.C. and Tomer, K.B. (1999) "An improved GC/MS-based procedure for the quantitation of the isoprostane 15-F2t-IsoP in rat plasma", Mol. Biotechnol. 18, 105–118.
   Google Scholar
• Adiyaman, M., Lawson, J.A., Khanapure, S.P., FitzGerald, G.A. and Rokach, J. (1998) "Total synthesis of 17,17,18,18-d4-iPF2alpha-VI and quantification of iPF2alpha-VI in human urine by gas chromatography/ mass spectrometry", Anal. Biochem. 26, 45–56.
   Google Scholar
• Proudfoot, J., Barden, A., Mori, T.A., Burke, V., Croft, K.D., Beilin, L.J. and Puddey, I.B. (1999) "Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid permddation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry", Anal. Biochem. 272, 209–215.
   PubMed Web of Science ®Google Scholar
• Li, H., Lawson, J.A., Reilly, M., Adiyaman, M., Hwang, S.W., Rokach, J. and FitzGerald, G.A. (1999) "Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine", Proc. Natl Acad. Sci. 96, 13381–13386.
   PubMed Web of Science ®Google Scholar
• Liang, Y, Wei, P., Duke, R.W., Reaven, PD., Harman, S.M., Cutler, R. and Heward, C.B. (2003) "Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglan-din-F(2alpha) in human urine using liquid chromato-graphy-tandem mass spectrometry", Free Radic. Biol. Med. 34, 409–418.
   PubMed Web of Science ®Google Scholar
• Sasaki, D.M., Yuan, Y, Gikas, K., Kanai, K., Taber, D., Morrow, J.D., Roberts, L.J., 2nd and Callewaert, D.M. (2002) "Enzyme immunoassays for 15-F2T isoprostane-M, an urinary biomarker for oxidant stress", Adv. Exp. Med. Biol. 507, 537–541.
   Google Scholar